G En1 E Lifesciences
Biotechnology, El Camino Real, Palo Alto, California, 95616, United States, 11-50 Employees
Phone Number: 65********
Who is GEN1E LIFESCIENCES
GEn1E Lifesciences is a Clinical-stage, multi-target company with a unique AI platform. They develop novel, next-generation, immunomodulatory therapies for rare & inflammatory diseases wi...
Read More
-
Headquarters: El Camino Real, Palo Alto, California, 95616, United States
-
Date Founded: 2018
-
Employees: 11-50
-
Revenue: $1 Billion and Over
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from GEN1E LIFESCIENCES
GEn1E Lifesciences Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding GEn1E Lifesciences
Answer: GEn1E Lifesciences's headquarters are located at El Camino Real, Palo Alto, California, 95616, United States
Answer: GEn1E Lifesciences's phone number is 65********
Answer: GEn1E Lifesciences's official website is https://gen1elifesci.com
Answer: GEn1E Lifesciences's revenue is $1 Billion and Over
Answer: GEn1E Lifesciences's SIC: 2836
Answer: GEn1E Lifesciences's NAICS: 541714
Answer: GEn1E Lifesciences has 11-50 employees
Answer: GEn1E Lifesciences is in Biotechnology
Answer: GEn1E Lifesciences contact info: Phone number: 65******** Website: https://gen1elifesci.com
Answer: GEn1E Lifesciences is a Clinical-stage, multi-target company with a unique AI platform. They develop novel, next-generation, immunomodulatory therapies for rare & inflammatory diseases with no effective treatments. GEn1E is supercharging the drug development cycle by applying AI to multiple-mechanism-of-action protein targets and their natural platform capabilitiescreating novel therapeutics at an unprecedented pace. Their AI platform has enabled them to develop a purpose-built therapy for ARDS to reduce its $20 billion cost on society (just in the USA). GEn1E has built a rich pipeline of 21+ novel and selective immunomodulators and has plans to accelerate 2 additional devastating diseases (beyond their lead indication) to IND in the next 12 months. Their AI platform enables tremendous pace and capital efficiency as demonstrated by their progress in ~2 years with seed capitala stark contrast to the typical spend of $100M+ and 7+ years exhibited in the pharmaceuticals / biotech industry. With ~90% of rare diseases having no therapeutic treatment at all, GEn1E is taking a giant swing that will hopefully bring life-saving therapies to the lives of patients in need. GEn1Es team has decades of experience in drug development and machine learning, and they graduated from YCombinator and Stanford-StartX in late 2019. GEn1E is based in Palo Alto, CA.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month